Vizgen Expands Single-Cell Spatial Transcriptomics Offering with Introduction of MERSCOPE® Ultra Platform and MERFISH 2.0 Chemistry
April 8, 2024 – Vizgen, Inc. the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, unveils the MERSCOPE® Ultra Platform and MERFISH 2.0 chemistry. These powerful tools are uniquely suited to supporting basic and translational research and will be commercially available in the second half of the year.
With 3x increased imaging area and 2x speed, coupled with enhanced MERFISH sensitivity, MERSCOPE Ultra will offer greater sample flexibility and throughput, accelerating both human and translational research.
The MERSCOPE Ultra Platform is a powerful new high plex in situ spatial multiomic analysis system. The MERSCOPE Ultra features the optimum combined capabilities of imaging area and throughput in a spatial transcriptomics imaging platform. The platform is capable of processing 3 cm2 of tissue on a single slide and acquires images at more than double the speed of the MERSCOPE Platform. Engineered for high-performance and optimized for throughput, MERSCOPE Ultra provides researchers with an industry-leading combination of imageable area, speed, and data quality to accelerate discovery and maximize the biology measured from every sample. Further, the system is the only spatial platform to offer two different size flow cells enabling users to adjust reagent consumption based on area imaged.
Read (Download) the full Press Release.